The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of pembrolizumab, binimetinib, and bevacizumab in patients with microsatellite-stable, refractory, metastatic colorectal cancer (mCRC).
 
Tyler Friedrich
No Relationships to Disclose
 
Patrick Jud Blatchford
Employment - BioMimetix; Clovis Oncology; Criterium
Consulting or Advisory Role - BioMimetix; Clovis Oncology; Criterium
 
Robert William Lentz
No Relationships to Disclose
 
S. Lindsey Davis
Honoraria - Bristol-Myers Squibb; Incyte; OncLive
Speakers' Bureau - Allergan (I); Teva (I)
Research Funding - AstraZeneca (Inst); Boston Scientific (I); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Halozyme (Inst); Incyte (Inst); Merck (Inst); OncoMed (Inst); Roche (Inst); Senhwa Biosciences (Inst)
 
Sunnie S. Kim
Consulting or Advisory Role - Astellas Pharma; Daiichi Sankyo/Lilly
Research Funding - Merck
 
Alexis Diane Leal
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Corcept Therapeutics (Inst); Exelixis (Inst); Hutchison MediPharma (Inst); Takeda (Inst)
 
Zoe Van De Voorde
No Relationships to Disclose
 
Matthew R Lee
Travel, Accommodations, Expenses - Bristol Myer Squibb
 
Meredith Waring
No Relationships to Disclose
 
Tiffany Cull
No Relationships to Disclose
 
Anne Martin
No Relationships to Disclose
 
S. Gail Eckhardt
No Relationships to Disclose
 
Wells A. Messersmith
Consulting or Advisory Role - Five Prime Therapeutics (Inst); QED Therapeutics
Research Funding - Alexo Therapeutics (Inst); Beigene (Inst); D3 (Inst); Immunomedics (Inst); OncoMed (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Christopher Hanyoung Lieu
Consulting or Advisory Role - HalioDx (Inst); Ipsen (Inst); Pfizer (Inst)
Research Funding - Merck (Inst)